Skip to main content
ATOM logo

ATOM · Atomera Inc · Documents

Track ATOM — free
$2.04 -0.27 (-11.69%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$79.73M
Shares
39.08M
Volume · Nov 20 1.15M Avg daily vol (3M) 577.16K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $65K down 51.9% 10-K filed Feb 24, 2026 Quarterly report FY2026 Q3 Revenue $0 10-Q filed Oct 30, 2026 Latest results Third-quarter net loss $6.0 million; cash and investments $34.8 million 8-K filed Oct 29, 2026 Earnings call Q3 2026 earnings call Held Oct 29, 2026
2026
Oct 30
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Nine-month net loss of $18.4 million amid continuing cash burn

Atomera reported a net loss of approximately $18.4 million and operating cash use of approximately $11.7 million for the nine months ended September 30, 2026, with cash, cash equivalents and short-term investments of approximately $34.8 million.

Revenue $0 Net loss $6.01M Diluted EPS -$0.15
Read from the MD&A section
3 source passages
The following discussion and analysis of the financial condition and results of operations of Atomera Incorporated should be read in conjunction with our financial statements and the accompanying notes that appear elsewhere in this Quarterly Report on Form 10-Q. For the nine months ended September 30, 2026 we had a net loss of approximately $18.4 million and used approximately $11.7 million of cash and cash equivalents in operations. As of September 30, 2026, we had cash, cash equivalents and short-term investments of approximately $34.8 million and working capital of approximately $30.6 million. Open the document at this passage
Oct 29
Earnings call
Gate-all-around progress and IQE manufacturing agreement

Atomera engaged three of four gate all-around customers and formed a joint development agreement with IQE to develop MST-enabled GAN on silicon.

3 source passages
We're now engaged with three of the four gate all-around customers, and we remain in active dialogue with the four. In this quarter, we announced something new, a route to manufacturing, in the form of a joint development agreement with IQE, announced last week. Under the JDA, IQE's GAN epitaxy, grown on MST silicon substrates, will be optimized to identify the best low-cost, high-performance RF GAN on silicon wafers possible. Open the document at this passage
Oct 29
Current report 8-K
Third-quarter net loss $6.0 million; cash and investments $34.8 million

Atomera reported a third-quarter 2026 net loss of ($6.0) million, or ($0.15) per share, versus ($5.6) million a year earlier. Cash, equivalents and short-term investments were $34.8 million at Sept. 30, 2026.

Financial results
2 source passages
The Company incurred a net loss of ($6.0) million, or ($0.15) per basic and diluted share in the third quarter of 2026, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025. The Company had $34.8 million in cash, cash equivalents and short-term investments as of Sept. 30, 2026, compared to $19.2 million as of December 31, 2025. Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $158K Net loss $6.34M Diluted EPS -$0.17
May 5
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $11K ▲ 175.0% Net loss $6.07M Diluted EPS -$0.17
Mar 27
Proxy statement DEF 14A Meeting May 12, 2026
Proxy statement AI summary on its way
Mar 17
Proxy statement PRE 14A Meeting May 12, 2026
Proxy statement AI summary on its way
Feb 24
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $65K ▼ 51.9% Net loss $20.17M Diluted EPS -$0.65
Feb 23
Current report 8-K
Other events AI summary on its way
2025
Mar 4
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $135K ▼ 75.5% Net loss $18.44M Diluted EPS -$0.68
2024
Showing 1–50 of 138 documents
Key facts CIK 1420520 CUSIP 04965B100 13F (30d) 110 filings 94 filers Visit website Investor relations